The impact of age on the epidemiology of atrial fibrillation hospitalizations

American Journal of Medicine

Volumn 127, Issue 2, 2014, Pages 158.e1-158.e7

  Naderi, Sahar ^a   Wang, Yun ^b   Miller, Amy L ^c   Rodriguez, Fátima ^c,d   Chung, Mina K ^a   Radford, Martha J ^e   Foody, Joanne M ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age; Atrial fibrillation; Epidemiology

Indexed keywords

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NURSING HOME; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VERY ELDERLY;

AGE; ATRIAL FIBRILLATION; EPIDEMIOLOGY;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROKE; UNITED STATES;

EID: 84892983315     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.10.005     Document Type: Article

References (28)

1. J. Camm 'Atrial fibrillation-an end to the epidemic?' Circulation 112 2005 iii
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
3. E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
4. A.S. Go, E.M. Hylek, and K.A. Phillips et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
5. M.H. Kim, S.S. Johnston, and B.C. Chu et al. Estimation of total incremental health care costs in patients with atrial fibrillation in the United States Circ Cardiovasc Qual Outcomes 4 2011 313 320
6. Y. Miyasaka, M.E. Barnes, and B.J. Gersh et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
7. E.J. Benjamin, P.S. Chen, and D.E. Bild et al. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop Circulation 119 2009 606 618
8. S.S. Chugh, J.L. Blackshear, and W.K. Shen et al. Epidemiology and natural history of atrial fibrillation: clinical implications J Am Coll Cardiol 37 2001 371 378
9. C.D. Furberg, B.M. Psaty, and T.A. Manolio et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241
10. J.L. Blackshear, S.L. Kopecky, and S.C. Litin et al. Management of atrial fibrillation in adults: prevention of thromboembolism and symptomatic treatment Mayo Clin Proc 71 1996 150 160
11. Overview of the Nationwide Inpatient Sample. Health Care Utilization Project. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
12. J. Chen, S.L. Normand, and Y. Wang et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
13. J.A. Dodson, Y. Wang, and M.M. Desai et al. Outcomes for mitral valve surgery among Medicare fee-for-service beneficiaries, 1999 to 2008 Circ Cardiovasc Qual Outcomes 5 2012 298 307
14. Hall MJ, Levant S, DeFrances C. Hospitalization for congestive heart failure: United States, 2000-2010. National Center for Health Statistics data brief. Hyattsville, MD; 2012.
15. W.M. Feinberg, J.L. Blackshear, and A. Laupacis et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 1995 469 473
16. N. Wanahita, F.H. Messerli, and S. Bangalore et al. Atrial fibrillation and obesity-results of a meta-analysis Am Heart J 155 2008 310 315
17. J.S. Healey, and S.J. Connolly Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target Am J Cardiol 91 2003 9G 14G
18. C.J. Ostgren, J. Merlo, and L. Rastam et al. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community Diabetes Obes Metab 6 2004 367 374
19. M. Rosiak, M. Dziuba, and M. Chudzik et al. Risk factors for atrial fibrillation: not always severe heart disease, not always so 'lonely' Cardiol J 17 2010 437 442
20. S.A. Lubitz, C. Ozcan, and J.W. Magnani et al. Genetics of atrial fibrillation: implications for future research directions and personalized medicine Circ Arrhythm Electrophysiol 3 2010 291 299
21. S.J. Connolly, M.D. Ezekowitz, and S. Yusuf et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
22. J.W. Eikelboom, L. Wallentin, and S.J. Connolly et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial Circulation 123 2011 2363 2372
23. D.Q. Rich, J.M. Gaziano, and T. Kurth Geographic patterns in overall and specific cardiovascular disease incidence in apparently healthy men in the United States Stroke 38 2007 2221 2227
24. L.B. Goldstein, R. Adams, and M.J. Alberts et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 113 2006 e873 e.923
25. D.P. Schauer, C.J. Moomaw, and M. Wess et al. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin J Gen Intern Med 20 2005 1114 1119
26. Overweight and obesity. Center for Disease Control and Prevention. Atlanta, GA: 2012.
27. J.Z. Ayanian, J.S. Weissman, and E.C. Schneider et al. Unmet health needs of uninsured adults in the United States JAMA 284 2000 2061 2069
28. Nationwide Inpatient Sample data elements. Agency for Healthcare Research and Quality.